Literature DB >> 19601992

A randomized double-blind pilot study of serum phosphorus normalization in chronic kidney disease: a new paradigm for clinical outcomes studies in nephrology.

Geoffrey A Block, Martha S Persky, Markus Ketteler, Bryan Kestenbaum, Ravi Thadhani, Laura Kooienga, David Spiegel, John Asplin, James Ehrlich, Vincent Dennis, Allen Nissenson, Glenn M Chertow, David C Wheeler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19601992     DOI： 10.1111/j.1542-4758.2009.00387.x

Source DB:  PubMed          Journal:  Hemodial Int        ISSN： 1492-7535            Impact factor:   1.812


× No keyword cloud information.
  6 in total

1.  Hypophosphatemic effect of niacin in patients without renal failure: a randomized trial.

Authors:  Darbie Maccubbin; Diane Tipping; Olga Kuznetsova; William A Hanlon; Andrew G Bostom
Journal:  Clin J Am Soc Nephrol       Date:  2010-03-18       Impact factor: 8.237

2.  A Pilot Randomized Trial of Ferric Citrate Coordination Complex for the Treatment of Advanced CKD.

Authors:  Geoffrey A Block; Martha S Block; Gerard Smits; Rupal Mehta; Tamara Isakova; Myles Wolf; Glenn M Chertow
Journal:  J Am Soc Nephrol       Date:  2019-07-05       Impact factor: 10.121

3.  Relationships between serum and urine phosphorus with all-cause and cardiovascular mortality: the Osteoporotic Fractures in Men (MrOS) Study.

Authors:  Julie R Dominguez; Bryan Kestenbaum; Michel Chonchol; Geoffrey Block; Gail A Laughlin; Cora E Lewis; Ronit Katz; Elizabeth Barrett-Connor; Steve Cummings; Eric S Orwoll; Joachim H Ix
Journal:  Am J Kidney Dis       Date:  2012-12-20       Impact factor: 8.860

4.  Effects of phosphate binder therapy on vascular stiffness in early-stage chronic kidney disease.

Authors:  Michael E Seifert; Lisa de las Fuentes; Marcos Rothstein; Dennis J Dietzen; Andrew J Bierhals; Steven C Cheng; Will Ross; David Windus; Víctor G Dávila-Román; Keith A Hruska
Journal:  Am J Nephrol       Date:  2013-08-07       Impact factor: 3.754

5.  Phosphate Metabolism in CKD Stages 3-5: Dietary and Pharmacological Control.

Authors:  Markus Ketteler
Journal:  Int J Nephrol       Date:  2011-05-23

6.  Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD).

Authors:  Marinella Ruospo; Suetonia C Palmer; Patrizia Natale; Jonathan C Craig; Mariacristina Vecchio; Grahame J Elder; Giovanni Fm Strippoli
Journal:  Cochrane Database Syst Rev       Date:  2018-08-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.